Clinical Reference DB v1.0
Research Protocols
A curated database of titration schedules, peptide stacks, and recovery methodologies sourced from clinical literature and community research.
BPC-157 + TB-500 Recovery Stack
A common research combination. Standard research protocols often cite BPC-157 at 250mcg to 500mcg twice daily, paired with TB-500 at 2mg to 5mg weekly (divided into 2 doses).
GLOW Protocol (BPC-157 + TB-500 + GHK-Cu)
A popular beauty/recovery stack. Reported research protocols often use a pre-mixed blend yielding daily injections of: BPC-157 (500mcg), TB-500 (500mcg), and GHK-Cu (2mg - 5mg). Daily administration is typical for the GHK-Cu component.
KLOW Protocol (GHK-Cu + BPC-157 + TB-500 + KPV)
The "Kickstart" blend. Reported research protocols typically aim for daily administration of: GHK-Cu (2mg-5mg), BPC-157 (500mcg), TB-500 (500mcg), and KPV (200mcg-500mcg). This often requires calculating volume based on the specific total vial concentration.
Retatrutide Titration (TRIUMPH Research Protocol)
TRIUMPH trial protocol. Month 1: 2.0mg weekly. Month 2: 4.0mg weekly. Month 3: 6.0mg (optional maintenance). Month 4: 9.0mg. Month 5: 12.0mg (Max).
Semaglutide Titration (Standard Research Protocol)
The STEP trial schedule. Month 1: 0.25mg weekly. Month 2: 0.5mg weekly. Month 3: 1.0mg weekly. Month 4: 1.7mg weekly. Month 5+: 2.4mg weekly (Max).
Tirzepatide Titration (Standard Research Protocol)
The standard 4-week titration schedule. Month 1: 2.5mg weekly. Month 2: 5.0mg weekly. Month 3: 7.5mg weekly. Month 4: 10.0mg weekly. Month 5: 12.5mg weekly. Month 6: 15.0mg weekly (Max).